1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione
C25H21FN4S — CID 133181119
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione
1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione (PubChem CID 133181119) has the molecular formula C25H21FN4S and a molecular weight of 428.54 g/mol. Its IUPAC name is 1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione.
Molecular Properties
| Compound Name | 1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione |
|---|---|
| PubChem CID | 133181119 |
| Molecular Formula | C25H21FN4S |
| Molecular Weight | 428.54 g/mol |
| Exact Mass | 428.15 |
| IUPAC Name | 1-benzyl-5-[1-(2-fluorophenyl)pyrrol-2-yl]-4-pyridin-2-ylimidazolidine-2-thione |
| SMILES | Fc1ccccc1-n1cccc1C1C(c2ccccn2)NC(=S)N1Cc1ccccc1 |
| InChI | InChI=1S/C25H21FN4S/c26-19-11-4-5-13-21(19)29-16-8-14-22(29)24-23(20-12-6-7-15-27-20)28-25(31)30(24)17-18-9-2-1-3-10-18/h1-16,23-24H,17H2,(H,28,31) |
| InChIKey | SGIJWFQLIICUMN-UHFFFAOYSA-N |
| XLogP | 5.18 |
| TPSA | 33.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.54 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 133181119 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.